About Careers MedBlog Contact us

FDA Approves Impella 2.5 Heart Pump for Angioplasty

by Julia Samuel on March 25, 2015 at 7:01 PM
Font : A-A+

FDA Approves Impella 2.5 Heart Pump for Angioplasty

FDA approved Impella 2.5 heart pump manufactured by Abiomed can to be used during elective and urgent high-risk percutaneous coronary interventions (PCI), commonly known as angioplasty.

The device helps the left ventricle by moving 2.5 liters of blood per minute, during procedures involving temporary coronary occlusions that would otherwise be too taxing on the already weak heart.


"The rigorous data from FDA clinical trials such as PROTECT I and PROTECT II demonstrate that complex, high-risk patients undergoing protected PCI with Impella 2.5 support experience reduced adverse events, improved quality of life and are able to return home faster with fewer repeat procedures," said William O'Neill, M.D., Henry Ford Hospital in Detroit.

Impella is the only hemodynamic support device proven safe and effective for high risk PCI. This heart team approach has also been utilized for the treatment strategy for heart valve replacement. The clinical team can decide the duration of use though it is intended for up to six hours of use.

Source: Medindia

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

FDA Approves Impella 2.5 Heart Pump for Angioplasty Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests